Profile data is unavailable for this security.
About the company
Uniphar PLC is an Ireland-based diversified healthcare service company. The Company is focused on improving access to pharmaco-medical products and therapies. It operates through three divisions: Uniphar Medtech, Uniphar Pharma, and Uniphar Supply Chain & Retail. Its Uniphar Medtech division provides outsourced services, specifically sales, distribution and support services to medical device manufacturers. Uniphar Pharma division operates a global business with valued services across the lifecycle of a pharmaceutical product. This division operates through its on demand and pharma services business units. Uniphar Supply Chain & Retail division provides both pre-wholesale and wholesale distribution of pharmaceutical, healthcare and animal health products to pharmacies, hospitals and veterinary surgeons in Ireland. It operates a network of pharmacies under the Life, Allcare, Hickey’s and McCauleys brands. It also provides services and support that help independent community pharmacies.
- Revenue in EUR (TTM)2.55bn
- Net income in EUR44.82m
- Incorporated1994
- Employees3.26k
- LocationUniphar PLC4045 Kingswood DriveCitywest Business ParkDUBLIN D24 VO6KIrelandIRL
- Phone+353 14287777
- Fax+353 14287776
- Websitehttps://www.uniphar.ie/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adcock Ingram Holdings Limited | 451.19m | 42.89m | 426.17m | 2.39k | 9.81 | 1.49 | -- | 0.9446 | 5.49 | 5.49 | 57.72 | 36.26 | 1.12 | 2.52 | 4.38 | -- | 10.68 | 10.50 | 14.81 | 14.90 | 34.32 | 32.38 | 9.51 | 9.34 | 0.9352 | -- | 0.0806 | 40.35 | 4.89 | 7.43 | 12.25 | 7.45 | -7.92 | 7.77 |
| Shanghai New World Co Ltd | 146.25m | 4.29m | 467.66m | 1.20k | 109.01 | 0.871 | -- | 3.20 | 0.0519 | 0.0519 | 1.77 | 6.50 | 0.2026 | 4.62 | 7.42 | 951,798.10 | 0.5858 | 0.5242 | 0.78 | 0.7249 | 38.56 | 33.70 | 2.89 | 2.71 | 1.52 | -- | 0.1222 | 82.75 | 33.39 | -16.40 | 160.85 | -35.00 | 53.61 | -25.42 |
| YSB Inc | 2.17bn | -407.35m | 589.37m | 6.31k | -- | 2.40 | -- | 0.2719 | -25.57 | -25.57 | 47.38 | 3.23 | -- | -- | -- | 2,900,894.00 | -- | -- | -- | -- | 10.26 | -- | -18.89 | -- | 1.01 | -- | 0.1002 | -- | 18.90 | -- | -114.23 | -- | -- | -- |
| Nu Skin Enterprises, Inc. | 1.76bn | -3.07m | 620.26m | 3.70k | -- | 0.8275 | 9.70 | 0.3517 | -0.0758 | -0.0758 | 37.80 | 16.30 | 1.07 | 1.90 | 29.99 | 514,858.10 | -0.1858 | 6.80 | -0.2298 | 8.90 | 68.42 | 73.45 | -0.174 | 5.26 | 1.24 | 7.94 | 0.3736 | 62.58 | -11.53 | -5.97 | -91.80 | -41.16 | -3.63 | 1.33 |
| Uniphar PLC | 2.55bn | 44.82m | 707.11m | 3.26k | 15.78 | 2.12 | 8.78 | 0.277 | 0.1641 | 0.1641 | 9.35 | 1.22 | 2.13 | 12.64 | 12.71 | 782,667.70 | 3.76 | 4.12 | 6.49 | 7.24 | 15.28 | 13.61 | 1.77 | 1.87 | 0.5634 | 3.22 | 0.5338 | 10.93 | 23.30 | 12.48 | -1.69 | 38.98 | 45.53 | -- |
| NanJing Pharmaceutical Co Ltd | 6.83bn | 75.07m | 751.42m | 4.90k | 9.95 | 0.8828 | -- | 0.11 | 0.4513 | 0.4513 | 41.07 | 5.09 | 1.63 | 8.33 | 3.33 | 10,903,610.00 | 2.22 | 2.32 | 7.44 | 8.94 | 6.04 | 6.41 | 1.36 | 1.30 | 1.13 | 2.91 | 0.6359 | 29.82 | 6.71 | 11.35 | -3.00 | 16.93 | -12.67 | 9.86 |
| Selcuk Ecza Deposu Ticaret ve Sanayi AS | 2.80bn | 6.39m | 907.22m | 6.03k | 141.89 | 2.10 | 49.44 | 0.3241 | 0.3594 | 0.3594 | 157.36 | 24.25 | 2.30 | 10.73 | 10.42 | 16,218,930.00 | 0.5255 | 3.16 | 1.41 | 8.40 | 9.38 | 9.37 | 0.2284 | 1.24 | 1.05 | -- | 0.1382 | 27.16 | 14.70 | 48.64 | -64.89 | -10.62 | 23.13 | 20.11 |
| DocMorris AG | 1.00bn | -121.45m | 960.00m | 1.45k | -- | 1.71 | -- | 0.9585 | -10.07 | 7.03 | 83.05 | 36.60 | 0.9863 | 11.36 | 10.50 | 667,214.10 | -11.96 | -12.92 | -15.23 | -15.74 | 20.98 | 16.84 | -12.13 | -10.87 | 1.34 | -2.39 | 0.4448 | -- | 4.13 | -4.29 | 31.29 | -- | -2.53 | -- |
| Neuca SA | 2.78bn | 35.92m | 960.07m | 5.19k | 27.36 | 3.87 | 14.63 | 0.3459 | 34.25 | 34.25 | 2,647.46 | 241.93 | 2.37 | 7.47 | 7.17 | 2,307,345.00 | 3.30 | 3.58 | 12.27 | 13.31 | 11.19 | 10.33 | 1.39 | 1.43 | 0.5034 | 4.22 | 0.3032 | 34.59 | 5.17 | 8.79 | 6.58 | 8.95 | -3.07 | 14.40 |
| Holder | Shares | % Held |
|---|---|---|
| Allianz Global Investors GmbHas of 02 Feb 2024 | 32.86m | 12.04% |
| Polar Capital LLPas of 02 May 2023 | 20.13m | 7.37% |
| Mackenzie Financial Corp.as of 22 Feb 2023 | 17.37m | 6.36% |
| Mackenzie Investments Europe Ltd.as of 30 Sep 2023 | 10.46m | 3.83% |
| Swedbank Robur Fonder ABas of 29 Feb 2024 | 9.96m | 3.65% |
| Amundi Asset Management SA (Investment Management)as of 24 Apr 2024 | 8.32m | 3.05% |
| Danske Bank A/S (Investment Management)as of 31 May 2024 | 5.11m | 1.87% |
| Allianz Global Investors GmbH (France)as of 30 Apr 2024 | 5.10m | 1.87% |
| Joh. Berenberg, Gossler & Co. KG (Investment Management)as of 31 May 2023 | 3.69m | 1.35% |
| FIL Investments Internationalas of 29 Feb 2024 | 3.04m | 1.12% |
